DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Yao JC, Fazio N, Singh S. et al.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet 2016;
387(10022): 968-977

Download Bibliographical Data

Search in:
Access: